To further prioritize these candidate MRs, we used a Cox proportional hazard model to assess the association of their MR activity with prostate cancer-specific survival (where activity for a given MR is defined based on the expression levels of its MR transcriptional targets, see Methods). The gene discussed is NR3C2; the disease is Familial prostate cancer.